SCHEMBL14908874

SCHEMBL14908874

O=C(O)N(Cc1ccccc1)[C@H](Cc1ccccc1)c1ncc[nH]1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.42
CYP2D6 P10635 1/20 0.42
LMNA P02545 3/20 0.41
GLA P06280 1/20 0.41
BLM P54132 1/20 0.41
PMP22 Q01453 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
ADRA2A P08913 1/20 0.39
ADRA2B P18089 1/20 0.39
ADRA2C P18825 1/20 0.39
TAAR1 Q96RJ0 2/20 0.39
HPGD P15428 1/20 0.38
CSNK1A1 P48729 1/20 0.37
TYRO3 Q06418 1/20 0.37
DYRK1B Q9Y463 1/20 0.37
CYP1A2 P05177 1/20 0.36
TP53 P04637 1/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2693545 0.91 CYP2D6 (0.36) TSHRCYP2D6LMNAGLABLM
SCHEMBL14909550 0.87 MEN1 (0.43) TSHRCYP2D6LMNAGLABLM
SCHEMBL4442877 0.75 TAAR1 (0.49) TSHRCYP2D6LMNAGLABLM
SCHEMBL2872633 0.73 TAAR1 (0.47) TSHRCYP2D6LMNAGLABLM
SCHEMBL27724873 0.72 CYP1A2 (0.47) CYP2D6LMNASMN1; SMN2ADRA2AADRA2B
SCHEMBL391686 0.72 CYP1A2 (0.47) CYP2D6LMNASMN1; SMN2ADRA2AADRA2B
SCHEMBL6432859 0.72 TAAR1 (0.46) TSHRCYP2D6LMNAGLABLM
SCHEMBL8904379 0.72 TAAR1 (0.35) TSHRCYP2D6LMNAGLABLM
SCHEMBL12011595 0.71 NISCH (0.49) TSHRCYP2D6LMNAGLABLM
SCHEMBL3982882 0.71 TSHR (0.36) TSHRCYP2D6LMNAGLABLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2589592-B1 NOVEL NICOTINAMIDE DERIVATIVES OR SALTS THEREOF FUJIFILM CORP (JP) 2018-08-22 EP disclosed
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 US disclosed
US-8809371-B2 2014-08-19 US disclosed
US-8772320-B2 2014-07-08 US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 US disclosed
EP-2589592-A1 NOVEL NICOTINAMIDE DERIVATIVES OR SALTS THEREOF FUJIFILM Corporation (JP) 2013-05-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF SYK, CD38, BTK TSHR 1886/4885CYP2D6 4006/4885LMNA 3649/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.